UBS Group AG is navigating market volatility, adjusting its stock price targets, and expressing concerns about the impact of US tariffs on the global economy.
UBS threatens to abandon Switzerland as a looming capital crunch could force the bank to relocate its headquarters, potentially crippling the country’s financial sector.
UBS Group AG has received regulatory approval to sell a stake in Credit Suisse’s China venture and has made adjustments to its stock price targets for several companies.
UBS Group made several updates, including downgrading FMC Corp’s shares and upgrading its own IBD Relative Strength Rating, while also highlighting potential market trends in technology and healthcare.